Zynerba Pharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
15 Aug 2023	Form 3: Jones Kenneth T, See Remarks Holds 79,025 shares of Common Stock
15 Feb 2022	Form 3: Parker Albert P, Chief Legal Officer No securities owned
20 Feb 2019	Form 3: Stephenson Pamela, Director No securities owned
16 Apr 2018	Form 3: Butler John P., Director No securities owned
25 Jan 2017	Form 3: Rosenberger Brian, VP, Commercial No securities owned
22 Sep 2016	Form 3: Fickenscher James E, Chief Financial Officer No securities owned
04 Aug 2015	Form 3: Cooper Warren D, Director No securities owned
04 Aug 2015	Form 3: Federici William J, Director No securities owned
04 Aug 2015	Form 3: Kisner Daniel L, Director No securities owned
04 Aug 2015	Form 3: Rapp Michael, 10% owner Holds 696,143 shares of Common Stock
04 Aug 2015	Form 3: Harrison Thomas L, Director No securities owned
04 Aug 2015	Form 3: Hanlon Suzanne M., General Counsel Holds 39,893 shares of Common Stock
04 Aug 2015	Form 3: Moch Kenneth I, Director No securities owned
04 Aug 2015	Form 3: Sebree Terri B, President Holds 178,746 shares of Common Stock
04 Aug 2015	Form 3: Baron Richard A, Chief Financial Officer
04 Aug 2015	Form 3: Anido Armando, Director Holds 332,512 shares of Common Stock
04 Aug 2015	Form 3: Rask Cynthia Ann, Director No securities owned

Comments